nVerses Capital’s Kura Oncology KURA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-26,023
Closed -$285K – 136
2026
Q2
$285K Buy
+26,023
New +$246K 0.44% 65
2024
Q4
– Sell
-1,300
Closed -$25.4K – 460
2024
Q3
$25.4K Buy
+1,300
New +$26.3K 0.01% 768

Other funds holding KURA

nVerses Capital's KURA Position: Q3 2026 in Review

nVerses Capital sold out of Kura Oncology (KURA) in Q3 2026, closing a stake of 26,023 shares — an estimated $285K sold.

nVerses Capital first reported a position in KURA in Q3 2024 and held it in 2 quarters. The position peaked at $285K in Q2 2026. 230 funds tracked by Wall St. Rank hold KURA as of Q3 2026.

  • nVerses Capital reported no remaining Kura Oncology position as of Q3 2026 after selling out during the quarter.
  • nVerses Capital sold 26,023 Kura Oncology shares in Q3 2026, an estimated $285K.
  • nVerses Capital first reported a position in Kura Oncology in Q3 2024 and held it in 2 quarters.
  • nVerses Capital's Kura Oncology position peaked at $285K in Q2 2026.
  • 230 funds tracked by Wall St. Rank held Kura Oncology as of Q3 2026.

Based on nVerses Capital's 13F filing for Q3 2026.